Cemdisiran by Alnylam Pharmaceuticals for Myasthenia Gravis: Likelihood of Approval

Cemdisiran is under clinical development by Alnylam Pharmaceuticals and currently in Phase III for Myasthenia Gravis.

eHealth app helps patients recover from major abdominal operations 30% faster

Through the use of eHealth application ikHerstel, patients recover from major abdominal operations 30% faster than patients who do not use the app.

July 6, 2023

IntegriChain acquires pharma advisory services firm FCS

The acquisition marks IntegriChain’s seventh expansion. Credit: Gorodenkoff/Shutterstock. IntegriChain, a provider of data-driven commercialisation solutions for the pharmaceutical industry, has acquired pharma advisory and managed

July 10, 2024

Doc on McConnell’s Freeze-Up; Medical Blackmail; Xmas for Nursing Students

The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. Emergency doctor @jtrebach shares his medical opinion following Senate Minority

September 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.